Tislelizumab Plus Chemo Slows Advanced Squamous NSCLC

Progression - free survival significantly longer with tislelizumab plus chemotherapy versus chemotherapy alone
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Pulmonology, Journal, Source Type: news